Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
January 11, 2021 08:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a...
Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep,...
Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 08, 2020 17:40 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and...
Seer Announces Pricing of Initial Public Offering
December 03, 2020 23:38 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and...
Seer Appoints Catherine Friedman to its Board of Directors
September 15, 2020 16:02 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and...
Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing
September 15, 2020 16:01 ET
|
Seer, Inc.
-- PrognomIQ to develop multi-omics tests leveraging Seer’s Proteograph product -- -- Seer to retain minority ownership in PrognomIQ -- REDWOOD CITY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) --...
Seer Announces Publication in Nature Communications Demonstrating Performance, Scalability and Utility of its Platform Technology for Deep, Unbiased Proteomics
July 22, 2020 07:00 ET
|
Seer, Inc.
Published results reveal differentiated ability of proprietary, engineered nanoparticle technology to enable large-scale proteomics studies to: Provide new insights into dynamic nature of the...
Seer Announces $55M Financing Led by Fidelity Management and Research Company
July 22, 2020 07:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 22, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on empowering exceptional scientific outcomes through the power of rapid, deep, unbiased...
Seer Announces Appointment of David R. Horn as Chief Financial Officer
May 20, 2020 07:00 ET
|
Seer, Inc.
-- Morgan Stanley executive brings extensive life sciences sector strategic and financial expertise to pioneering proteomics company -- REDWOOD CITY, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Seer,...
Seer Announces Appointment of Omead Ostadan as President and Chief Operating Officer
May 12, 2020 08:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on commercializing a proprietary solution that uniquely enables efficient, unbiased, and deep...